Day: December 28, 2022

SANTA CLARA, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) — Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that David Clapper, who has served as President and Chief Executive Officer since 2011, has chosen to retire. The Company’s board of directors (the Board) has appointed industry executive Todd Usen as President and Chief Executive Officer of Minerva Surgical and a member of the Board to succeed Mr. Clapper effective January 2, 2023. To ensure a smooth leadership transition, Mr. Clapper will continue to serve in his role through Mr. Usen’s first day of employment and has entered into a consulting agreement for 12 months following his retirement. “On behalf of the Board, the management team, and Minerva...

Please see attached major shareholder announcements.AttachmentsSI_4.1.20_Eydubl._vegna_breytinga_a_hlut_atkvaedisrettar_2022 – Samherji Holding ehfSI_4.1.20_Eydubl._vegna_breytinga_a_hlut_atkvaedisrettar_2022 – A03 ehf

TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) — Yamana Gold Inc. (TSX:YRI; NYSE:AUY; LSE:AUY) (“Yamana” or the “Company”) is pleased to announce that the management information circular (the “Information Circular”) and related meeting and proxy materials in connection with the special meeting of shareholders (the “Yamana Meeting”) scheduled to be held on January 31, 2023 has been filed and made publicly available. The purpose of the Yamana Meeting is to seek approval for the previously announced arrangement with Agnico Eagle Mines Limited (“Agnico Eagle”) and Pan American Silver Corp. (“Pan American”) involving the acquisition by Pan American of all of the issued and outstanding common shares of the Company and the sale by Yamana of its Canadian assets, including certain subsidiaries and partnerships which hold Yamana’s interests in...

CORAL GABLES, Fla., Dec. 28, 2022 (GLOBE NEWSWIRE) — Amerant Bancorp Inc. (NASDAQ: AMTB) (the “Company”), today announced it will release fourth quarter 2022 earnings results on Thursday, January 19th, after the market closes. Once released, investors may access Amerant’s earnings results at https://investor.amerantbank.com by choosing “Quarterly Results” under the “Financials” heading. On Friday, January 20, 2023, Jerry Plush, Chairman and Chief Executive Officer, and Carlos Iafigliola, Chief Financial Officer, will host a conference call at 9:00 AM ET to discuss the Company’s financial and operating results for the quarter. Conference Call Details Telephone Access: To be able to dial-into the call, please pre-register at: https://register.vevent.com/register/BI03957bf7cec64a4fb1eac6fc7e33f759 Participants who plan to ask questions...

The credit facility will enable Cellectis to support the development of its UCART product candidates pipelineThe credit facility consists of three tranches of €20 million, €15 million, and €5 million respectively, each redeemable in fine in 6 yearsThe credit facility is part of the European Investment Bank’s strategy to support biotech companies developing a high-level of expertise in various therapeutic areas with significant unmet medical needsPARIS, Dec. 28, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company“), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it has entered into a €40 million credit facility agreement with the European Investment Bank (“EIB”) (the “Finance Contract”). The...

TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) — Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that, on December 27, 2022, the Nasdaq Listing Qualifications Staff (the “Staff”) notified the Company that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as of December 26, 2022, the Company’s securities would be delisted unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing, which request will stay any further action by the Staff at least pending the issuance of the Panel’s decision...

SUNNYVALE, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Silk Road Medical’s management is scheduled to present on Tuesday, January 10, 2023 at 4:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/. About Silk Road MedicalSilk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The Company has pioneered a new approach for the treatment...

Private concert to benefit Tyler Robinson Foundation and 35+ local Las Vegas charitiesImagine Dragons x Dolby Dolby Laboratories and Imagine Dragons, the multi-platinum, GRAMMY®-winning band, are kicking off CES 2023 with a private concert in Dolby Atmos at Dolby Live at Park MGM on Thursday, January 5 at 9 p.m. PT.LAS VEGAS, Dec. 28, 2022 (GLOBE NEWSWIRE) — Dolby Laboratories, a leader in immersive entertainment experiences, and Imagine Dragons, the multi-platinum, GRAMMY®-winning band, are kicking off CES 2023 with a private concert in Dolby Atmos at Dolby Live at Park MGM on Thursday, January 5 at 9 p.m. PT. The concert will benefit Tyler Robinson Foundation (TRF), Imagine Dragons’ nonprofit organization dedicated to supporting families facing a pediatric cancer diagnosis, and over 35 local charities serving underserved...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRESERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 28, 2022 (GLOBE NEWSWIRE) — North Arrow Minerals Inc. (TSXV-NAR) (“North Arrow” or the “Company”) announces that it has closed the non-brokered private placement of non-flow-through units announced on November 21, 2022. The concurrent non-brokered flow-through private placement also announced on November 21, 2022 has been cancelled. The Company has issued 16,700,000 units priced at $0.05 per unit (the “Units”) for gross proceeds of $835,000. Each Unit issued under the private placement consisted of one common share in the capital of the Company and one transferrable common share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one additional common share of the Company...